Trial Scout

Long-Term Safety and Efficacy of Elagolix in Combination With Estradiol/ Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Study Location

Hamburg Regional Gynecology Group

ClinicalTrials.gov Identifier: NCT03271489
Recruitment Status: Recruiting
First Posted: 9/5/2017 12:00:00 AM
Last Update Posted: 5/20/2019 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Condition or Disease

Hemorrhage
Leiomyoma
Menorrhagia
Myofibroma

Intervention/Treatment

Other: Elagolix Placebo / Tablets

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >